Nonbinding futility rule [Two-Stage / GS Designs]

posted by Ben – 2018-06-15 15:58 (759 d 18:41 ago) – Posting: # 18908
Views: 7,976

Dear Detlew,

» My first thought was: Set fCpower = 1, that results in do not use the power futility criterion. This gives n2=16 for mittyri's example
», CV1=0.2575165, n1=38, fCpower=1).
» Your suggestion
», CV1=0.2575165, n1=38, ssr.conditional = "error")
» gives also n2=16. Astonishing or correct?

This is correct. Please note that if fCpower = 1, then (as intended) the futility criterion regarding power of stage 1 never applies. If you then encounter a scenario where power of stage 1 is greater than targetpower (this must not happen, but it can happen), then the conditional estimated target power will be negative. Thus, we would have a problem with this being the target power for sample size calculation. To avoid this from happening the function automatically sets the target power for recalculation to targetpower (which is equivalent to ssr.conditional = "error"). See 'Details' in the man page.

» Avoiding the conditional sample size re-estimation, i.e. using the conventional sample size re-estimation via
», CV1=0.2575165, n1=38, ssr.conditional = "no")
» gives n2=4. Ooops? Wow!

I have to think about that :confused:

» IIRC the term "nonbinding" in the context of sequential designs is used for flexibility in stopping or continuing due to external reasons. Do we have such here?
For example?

» Binding, nonbinding - does it have an impact on the alpha control? I think not, but are not totally sure.
Non-binding: Type 1 error is protected, even if the futility criterion is ignored.
Binding: Type 1 error is protected only if the futility criterion will be adhered to. ('Binding' is not common practice, authorities don't want this).

Best regards,

Complete thread:

 Admin contact
20,834 posts in 4,358 threads, 1,449 registered users;
online 31 (2 registered, 29 guests [including 17 identified bots]).
Forum time: 10:40 UTC (Europe/Vienna)

[Those] who have an excessive faith in their theories or in their
ideas are not only poorly disposed to make discoveries, but they
also make very poor observations.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz